Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online July 23, 2007
Diabetes 56:2523-2532, 2007
DOI: 10.2337/db07-0040
© 2007 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow All Versions of this Article:
db07-0040v1
db07-0040v2
56/10/2523    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, J. Z.
Right arrow Articles by Li, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, J. Z.
Right arrow Articles by Li, P.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Cideb Regulates Diet-Induced Obesity, Liver Steatosis, and Insulin Sensitivity by Controlling Lipogenesis and Fatty Acid Oxidation

John Zhong Li1, Jing Ye2,3, Bofu Xue1, Jingzhong Qi2, Jing Zhang3, Zhihong Zhou4, Qing Li3, Zilong Wen4, and Peng Li1,2

1 Department of Biology, Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong
2 Protein Science Laboratory of Ministry of Education, Department of Biological Sciences and Biotechnology, Tsinghua University, Beijing, China
3 Department of Pathology, Fourth Military Medical University, Xi'an, China
4 Institute of Molecular and Cell Biology, Singapore

Address correspondence and reprint requests to Dr. Peng Li, Department of Biological Sciences and Biotechnology, Tsinghua University, Beijing, China. E-mail: li-peng{at}mail.tsinghua.edu.cn

Abbreviations: ACC, acetyl-CoA carboxylase; BAT, brown adipose tissue; CPT, carnitine-palmitoyl transferase; FAS, fatty acid synthase; G6P, glucose-6-phosphatase; GTT, glucose tolerance test; IRS, insulin receptor substrate; ITT, insulin tolerance test; NEFA, nonesterified fatty acid; PGC, peroxisome proliferator–activated receptor {gamma} coactivator; PPAR, peroxisome proliferator–activated receptor; SCD1, stearol-CoA desaturase 1; SREBP1c, sterol response element binding protein 1c; TAG, triacylglycerol; WAT, white adipose tissue

OBJECTIVE—Our previous study suggests that Cidea, a member of Cide family proteins that share sequence homology with the DNA fragmentation factor and are expressed at high levels in brown adipose tissue, plays an important role in the development of obesity. Cideb, another member of Cide family protein, is highly expressed in the liver. We would like to understand the physiological role of Cideb in the regulation of energy expenditure and lipid metabolism.

RESEARCH DESIGN AND METHODS—We generated Cideb-null mice by homolog recombination and then fed both wild-type and Cideb-null mice with high-fat diet (58% fat). We then characterized the animals’ adiposity index, food intake, whole-body metabolic rate, liver morphology, rate of fatty acid synthesis and oxidation, insulin sensitivity, and gene expression profile.

RESULTS—Cideb-null mice had lower levels of plasma triglycerides and free fatty acids and were resistant to high-fat diet–induced obesity and live steatosis. In addition, Cideb mutant mice displayed significantly increased insulin sensitivity and enhanced rate of whole-body metabolism and hepatic fatty acid oxidation. More importantly, Cideb-null mice showed decreased lipogenesis and reduced expression levels of acetyl-CoA carboxylase, fatty acid synthase, and stearol-CoA desaturase. We further demonstrated that expression levels of sterol response element binding protein 1c was significantly decreased in Cideb-deficient mice.

CONCLUSIONS—Our data demonstrate that Cideb is a novel important regulator in lipid metabolism in the liver. Cideb may represent a new therapeutic target for the treatment of obesity, diabetes, and liver steatosis.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.